A complete application in a minute
Tailored resume and cover letter, ready to send.
ALRT, a leader in diabetes care solutions, seeks an experienced Managed Care Lead to drive the US managed care strategy, contract negotiations, and market access. The role collaborates with the Head of Sales in the US to implement the sales and marketing plan and reports to the Head of Global Commercial and Business Development.
The candidate will guide formulary access, optimize profitability, and oversee a team responsible for strategic account management and compliant sales practices.
At ALRT, we believe people with diabetes should have the freedom to enjoy active lives. We are searching for an experienced Managed Care Lead to run the United States Managed Care Team. The person will have proven success in managed care contracting and negotiation skills to drive access in the U.S. A strategic thinker will work closely with the Head of Sales in the US to implement the Sales and Marketing Plan. This person will report directly to the Head of Global Commercial and Business Development.
you can have a good job that can grow into a great career
This job description reflects management’s assignment of essential functions. Nothing in this job description restricts management’s right to assign or reassign duties and responsibilities to this job at any time.
ALR Technologies is an equal opportunity employer that is committed to diversity and inclusion in the workplace. We prohibit discrimination and harassment of any kind based on race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), national origin, age (40 or older), disability or genetic information, or any other protected characteristic as outlined by federal, state, or local laws.
ALR Technologies is a data management company that developed the ALRT Diabetes Solution, a comprehensive approach to diabetes care that includes: an FDA-cleared and HIPAA compliant diabetes management system that collects data directly from blood glucose meters and continuous glucose monitoring devices; a patent pending Predictive A1C algorithm to track treatment success between lab reports and an FDA-cleared Insulin Dosing Adjustment program. Currently, the Company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data.
In addition, the animal health division has identified an unmet need in diabetes care and has developed a solution to assist veterinarians in determining the effectiveness of insulin and helping to identify the appropriate dose and frequency of administration for companion animals. Thus, delivering the same optimization of diabetic drug therapies to pets as to humans.